Breaking Preakness Stakes Date Announcement Looms Amidst Triple Crown Spacing Debate Connecticut DOC to End In-Cell Restraints Under Settlement Abdul El-Sayed Secures Narrow Victory in Michigan Democratic Senate Primary Democrats See Mixed Results, Trump-Endorsed Republicans Victorious in Tuesday Primaries Russian Strikes Kill 17 in Kyiv Region, Ukrainian President Says

Wednesday August 5, 2026

Reporter

SHY Therapeutics

1Articles Published

4Communities Covered

Published Articles

Press Release

SHY Therapeutics Announces the First Patient Has Been Dosed in Phase 1 Clinical Trial Evaluating SHY-ONC6, a Novel, Oral Proteasome Inhibitor for the Treatment of Solid Tumors

Aug 4